ArticleStem cells and development2014

Inhibition of DNA topoisomerase II selectively reduces the threat of tumorigenicity following induced pluripotent stem cell-based myocardial therapy.

Saranya P Wyles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.